RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$33.80
-18.66%
Mkt Cap $1.98B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (11 analysts)
$56.40
Range $43.00 – $66.00
Implied Upside
+66.9%
Consensus $56.40 vs current $33.80